arsenic has been researched along with Cancer, Embryonal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, E; Bockstaller, M; Chan, JA; Chavez, L; Dorostkar, MM; Glass, R; Kool, M; Korshunov, A; Lambo, S; Meister, V; Merk, DJ; Neumann, JE; Neumann, P; Nowak, J; Renner-Müller, I; Schindler, P; Schneider, MR; Schüller, U; Shakarami, M; Sharma, T; Taketo, MM; von Hoff, K; Warmuth-Metz, M; Wefers, AK | 1 |
| Beer, TM; Crawford, ED; Dreicer, R; Margolin, KA; Nichols, CR; Quinn, DI; Raghavan, D; Stephenson, WT; Tangen, CM | 1 |
| Cohn-Cedermark, G; Kälkner, KM; Ullén, A; Wersäll, P | 1 |
1 trial(s) available for arsenic and Cancer, Embryonal
| Article | Year |
|---|---|
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies.
Topics: Adult; Antineoplastic Agents; Arrhythmias, Cardiac; Arsenic Trioxide; Arsenicals; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Oxides; Pneumonia; Respiratory Distress Syndrome; Survival Rate; Testicular Neoplasms; Treatment Outcome | 2006 |
2 other study(ies) available for arsenic and Cancer, Embryonal
| Article | Year |
|---|---|
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Down-Regulation; Gene Expression Profiling; Hedgehog Proteins; Humans; Immunohistochemistry; Mice; Mice, Transgenic; MicroRNAs; Neoplasms, Germ Cell and Embryonal; Oxides; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Signal Transduction; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2017 |
Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer.
Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Fatal Outcome; Humans; Male; Neoplasms, Germ Cell and Embryonal; Oxides; Prognosis; Time Factors; Treatment Failure | 2007 |